What I would focus on, if I were you, if you could communicate one message, and I think it needs to be communicated to professionals, and it needs to be communicated to the public, is the striking parallel that IEN is a disease, that carcinogenesis is a disease. You don't just wake up with cancer. There is a process leading to interepitheleal neoplasia and this process takes many, many years, and is quite analogous to the athrogenic process leading to heart disease. And therefore, people need to become much more sensitive to undergoing screening, early detection of precancerous lesions. And that they need to be aware that if there is a disease, carcinogenesis with IEN as a manifestation of that disease, then treatments need to be developed for the disease process, not simply the end product. And that prevention really needs to be thought of in terms of treatment of IEN. The term "prevention" by many is considered "soft." What we really are talking about is the treatment of IEN where the treatment is pre-cancer. And that to me would be of major benefit. And whether that is achieved through dietary intervention, or, it's going to be achieved through a combination of early detection, and appropriate intervention, be it dietary or medicinal.